Dipole Density Mapping of Right and Left Atrial Supraventricular Tachycardia

NCT01914575 — Not applicable, Withdrawn, Acutus Medical

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Dipole Density Right (and Left) Atrial Mapping and Assessment of Therapy In Complex Supraventricular Tachycardia

RegistryNCT01914575, acronym DDRAMATIC-SVT
StatusWithdrawn - Site never got up and running due to institutional issues
PhaseNot applicable
Study typeInterventional; na, single group, masking: none, diagnostic
SponsorAcutus Medical (Industry)
ConditionsSupraventricular Tachycardia
InterventionsMapping with the Acutus Medical System followed by Ablation (Device)
Datesstart 2014-01-22 (estimated), primary completion 2016-05-16, completion 2016-05-16, first posted 2013-08-02, last updated 2019-01-31
Locations1 site in Ireland

Related Papers Related Patents Related Grants Related Experts
All trials for Supraventricular Tachycardia All trials of Mapping with the Acutus Medical System followed by Ablation

-Summary

Use of dipole density mapping to identify activation in complex supraventricular tachycardias

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Dipole Density MappingExperimentalDevice: Mapping with the Acutus Medical System followed by Ablation
  • Mapping with the Acutus Medical System followed by Ablation (Device)

+Outcome measures

Primary outcomes

  • The number of patients with device-related complications [7 days]
  • The number of patients for which activation maps can be created [7 days]

+Eligibility

Sex: All, ages: 18 Years to 75 Years

Inclusion Criteria:

1. aged 18 to 75 years
2. scheduled for ablation of atypical atrial flutter or paroxysmal atrial fibrillation
3. able and willing to give informed consent

Exclusion Criteria:

1. implanted prosthetic, artificial, or repaired cardiac valves in the chamber being mapped, permanent pacemaker or ICD leads in the chamber being mapped, and/or hypercoagulopathy or an inability to tolerate anticoagulation .
2. myocardial infarction within the prior two months
3. cardiac surgery within the prior three months
4. intracardiac thrombus
5. clinically significant tricuspid valve regurgitation or stenosis
6. any cerebral ischemic event in the prior six months
7. pregnant or nursing
8. currently enrolled in any other clinical investigation

+Locations (1)

FacilityCityCountryStatus
St. Vincent's University HospitalDublinIreland

+Investigators

  • David Keane, MD, Principal investigator, St Vincent's University Hospital, Ireland